Todd C. Brady
2018
In 2018, Todd C. Brady earned a total compensation of $2.9M as President and Chief Executive Officer at Aldeyra Therapeutics, a 21% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $253,000 |
|---|---|
| Option Awards | $1,288,517 |
| Salary | $506,000 |
| Stock Awards | $826,838 |
| Total | $2,874,355 |
Brady received $1.3M in option awards, accounting for 45% of the total pay in 2018.
Brady also received $253K in non-equity incentive plan, $506K in salary and $826.8K in stock awards.
Rankings
In 2018, Todd C. Brady's compensation ranked 4,053rd out of 14,244 executives tracked by ExecPay. In other words, Brady earned more than 71.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,053 out of 14,244 | 72nd |
Division Manufacturing | 1,492 out of 5,765 | 74th |
Major group Chemicals And Allied Products | 528 out of 2,128 | 75th |
Industry group Drugs | 442 out of 1,817 | 76th |
Industry Pharmaceutical Preparations | 341 out of 1,391 | 76th |
Source: SEC filing on April 22, 2019.
Brady's colleagues
We found three more compensation records of executives who worked with Todd C. Brady at Aldeyra Therapeutics in 2018.
News
Aldeyra Therapeutics CEO Todd Brady's 2023 pay jumps 29% to $3.7M
April 22, 2024
Aldeyra Therapeutics CEO Todd Brady's 2022 pay slips 17% to $2.9M
May 23, 2023
Aldeyra Therapeutics CEO Todd Brady's 2021 pay jumps 43% to $3.5M
April 25, 2022
Aldeyra Therapeutics CEO Todd Brady's 2019 pay jumps 44% to $4.1M
April 27, 2020
Aldeyra Therapeutics CEO Todd Brady's 2018 pay jumps 21% to $2.9M
April 22, 2019